nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.06.2019 | editorial

Saving lives with lung cancer screening

verfasst von: Prim. Univ.-Prof. Dr. Wolfgang Hilbe, PD Dr. med. univ. Andreas Pircher

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Excerpt

Lung cancer is the number one reason for cancer-related death in Austria and many other countries, especially due the fact that the majority of patients are diagnosed at an advanced stage of the disease. Two large trials (NLST and NELSON) proved the efficacy of low-dose CT (LD-CT) for lung cancer screening [1, 2]. Lung cancer deaths were decreased and early diagnosis facilitated curative treatment options. Thus, the risk to die from lung cancer was reduced by 26% in the NELSON trial. …

Vorheriger Artikel Overcoming resistance and bypassing checkpoints—possible new therapeutic frontiers in oncology

Nächster Artikel memo—publisher’s report 2018

National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.CrossRef

De Koning H, Van Der Aalst C, Ten Haaf K, Oudkerk M. PL02.05 effects of volume CT lung cancer screening: mortality results of the NELSON randomised-controlled population based trial. J Thorac Oncol. 2018;13(10):185.CrossRef

Neuberger M. Tobacco control: prevention and cessation in Europe. Memo. 2019;12. https://doi.org/10.1007/s12254-019-0485-6.

Asshoff M, Weiss G, Tancevski I. Whom to screen? A view on lung cancer screening from the pneumologist’s perspective. Memo. 2019;12. https://doi.org/10.1007/s12254-019-0501-x.

Widmann G. Challenges in implementation of lung cancer screening—radiology requirements. Memo. 2019;12. https://doi.org/10.1007/s12254-019-0490-9.

Kocher F, Pall G. Lung cancer screening from the oncologist’s perspective. Memo. 2019;12. https://doi.org/10.1007/s12254-019-0492-7.

Ng C, Maier H, Augustin F. Lung cancer screening—the surgeon’s perspective. Memo. 2019;12. https://doi.org/10.1007/s12254-019-0502-9.

Titel: Saving lives with lung cancer screening
verfasst von: Prim. Univ.-Prof. Dr. Wolfgang Hilbe
PD Dr. med. univ. Andreas Pircher
Publikationsdatum: 01.06.2019
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 2/2019
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-019-0496-3

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Obituary for Professor Michael Steurer

Lung cancer screening—the surgeon’s perspective

Solitary scalp metastatic lesion as a sign of breast cancer recurrence—a case report

Resistance to chemotherapy and anti-angiogenic therapy in ovarian cancer

Response assessment in non-small cell lung cancer immunotherapy: initial experiences in utilizing FDG PET/CT and the PD-1 blocker nivolumab

Correction to: Seasonal fever for 11 years! A presentation of hemophagocytic lymphohistiocytosis secondary to marginal zone lymphoma